4
Changes in Ownership
GeneDx Holdings Corp. Filed Acc 0001689575-26-000015
CHIEF EXECUTIVE OFFICER sold 3,678 shares at $86.75 ($319,059)
- CHIEF EXECUTIVE OFFICER acquired 6,546 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Stueland Katherine CHIEF EXECUTIVE OFFICER | 2026-03-09 | Option exercise | +6,546 | 48,633 | D | ||
| Stueland Katherine CHIEF EXECUTIVE OFFICER | 2026-03-09 | Sale | −3,678 | $86.75 | $319,059 | 44,955 | D |
| Derivatives | |||||||
| Stueland Katherine CHIEF EXECUTIVE OFFICER | 2026-03-09 | Option exercise · Restricted Stock Unit | −6,546 | 19,640 | D | ||
| Open-market sales · 3,678 sh · avg $86.75 · $319,059 | |||||||
Loading xslF345X05/form4-03112026_080333.xml…